Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27200268 | 0.93 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL872808 | 0.86 | ALOX15 (0.57) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL3152826 | 0.83 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL16902070 | 0.83 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955365 | 0.83 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955363 | 0.83 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL872688 | 0.81 | ALOX15 (0.61) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL1292971 | 0.80 | ALOX15 (0.59) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| Citronellal SCHEMBL726176 | 0.79 | ALOX15 (0.46) | ALOX15ALDH1A1LMNANFE2L2USP2 | |
| SCHEMBL8397532 | 0.79 | ALOX15 (0.67) | ALOX15ALDH1A1NFE2L2USP2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9358191-B2 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| US-8961946-B2 | Hair processing agent and method for permanent waving hair | SHOWA DENKO K.K. (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20140271522-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-09-18 | — | — | US | disclosed |
| US-8778320-B2 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-1561476-B1 | DEODORANT COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2014-02-12 | — | — | EP | disclosed |
| EP-2618856-A1 | DEODORANT COMPOSITION FOR SULFIDES | Takasago International Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| CN-103189076-A | Deodorant composition for sulfides | TAKASAGO PERFUMERY CO LTD | 2013-07-03 | — | — | CN | disclosed |
| US-20130136713-A1 | DEODORANT COMPOSITION FOR SULFIDES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-05-30 | — | — | US | disclosed |
| WO-2012039516-A1 | DEODORANT COMPOSITION FOR SULFIDES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-03-29 | — | — | WO | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| CN-101292942-A | Dermatologic preparation composition containing gamma-oryzanol | KOWA CO (JP) | 2008-10-29 | — | — | CN | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| CN-100376292-C | Deodorant composition | TAKASAGO PERFUMERY CO LTD (JP) | 2008-03-26 | — | — | CN | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| CN-1732019-A | Deodorant composition | TAKASAGO PERFUMERY CO LTD (JP) | 2006-02-08 | — | — | CN | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | ALOX15 218/4885ALDH1A1 672/4885LMNA 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.